NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The complaint alleges that defendants caused the Company to issue materially misleading statements and/or omit material information concerning the Company's second Phase III study for MDX in adults with attention deficit hyperactivity disorder ("ADHD"), the "MDX Evaluation in Adults – Study of Response and Efficacy," or the "MEASURE" study. The complaint alleges these misstatements and omissions by Alcobra violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
Investors have 60 days from today to file a motion, with the court, for appointment as a lead plaintiff in this lawsuit.
Lifshitz & Miller has extensive experience representing investors in the prosecution of securities class actions and shareholder derivative litigation in state and federal courts across the country.
ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP. The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-files-class-action-lawsuit-against-alcobra-ltd-300409673.html
SOURCE Lifshitz & Miller Law Firm